Related Experiment Video
Updated: Mar 3, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma
Keishi Sugimachi1, Miki Nishio, Shinichi Aishima
1Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
Objective:
MOB1, a core component of the Hippo signaling pathway, suppresses cell proliferation, and MOB1 liver conditional knockout mice develop intrahepatic cholangiocarcinoma (ICC). However, its clinical significance in human ICC has not been established. The aim of this study was to characterize protein levels and the role of Hippo and TGF pathways in ICCs.
Methods:
The protein levels of yes-associated protein 1 (YAP1), MOB1, Smad2, and TGFβ2 in 88 ICC cases were analyzed. Protein level was graded by a scoring system; then, the clinicopathological factors, including prognosis, were analyzed based on protein level.
Results:
Nuclear overexpression of YAP1 was seen in 28 cases (31.8%), and it was significantly associated with a poor overall survival rate (p = 0.01). MOB1 expression decreased in 42 cases (47.7%) and was associated with a poor overall survival rate (p = 0.02). SMAD2 nuclear localization was significantly correlated with a high YAP1 level independent of TGFβ2. Multivariate analysis revealed that a high YAP1 level, a low MOB1 level, and lymphatic permeation were independent risk factors for overall survival.
Conclusions:
These results showed that key components of the Hippo signaling pathway are aberrantly expressed and associated with the malignant potential of human ICC.
Insights
Aberrant expression of Hippo pathway components, including YAP1 and MOB1, is linked to poor survival in intrahepatic cholangiocarcinoma (ICC). These findings highlight potential therapeutic targets for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Signaling Pathways
Background:
- The Hippo signaling pathway, regulated by MOB1, is crucial for controlling cell proliferation.
- Loss of MOB1 function in mice leads to intrahepatic cholangiocarcinoma (ICC).
- The clinical relevance of the Hippo pathway in human ICC remains unclear.
Purpose of the Study:
- To investigate the protein levels of key Hippo pathway components, YAP1 and MOB1, in human ICC.
- To explore the role of the Hippo and TGF pathways in ICC pathogenesis.
- To correlate protein expression with clinicopathological factors and patient prognosis.
Main Methods:
- Analysis of yes-associated protein 1 (YAP1), MOB1, Smad2, and TGFβ2 protein levels in 88 ICC patient samples.
- Quantification of protein expression using a scoring system.
- Statistical analysis of protein levels against clinicopathological factors and overall survival.
Main Results:
- Nuclear YAP1 overexpression (31.8%) correlated significantly with poor overall survival (p=0.01).
- Decreased MOB1 expression (47.7%) was also associated with a poor prognosis (p=0.02).
- High YAP1 levels were linked to SMAD2 nuclear localization, independent of TGFβ2, with high YAP1, low MOB1, and lymphatic permeation identified as independent risk factors for survival.
Conclusions:
- Key components of the Hippo signaling pathway, YAP1 and MOB1, are frequently dysregulated in human ICC.
- Aberrant expression of these proteins is associated with increased malignant potential and poorer patient outcomes.
- These findings suggest that the Hippo pathway plays a significant role in ICC progression and may represent therapeutic targets.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...